-
Keep Eyes on: Aldeyra Therapeutics (NASDAQ:ALDX), Rex Energy Corporation (NASDAQ:REXX), BOK Financial Corporation (NASDAQ:BOKF), Cytokinetics, Incorporated (NASDAQ:CYTK), Cesca Therapeutics Inc. (NASDAQ:KOOL)
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer and Mr. Stephen Tulipano, Chief Financial Officer of Aldeyra, will participate in the Canaccord Genuity Rare Disease, BioPharma One-on-One Day, being held on Tuesday, February 3, 2015 in New York, NY. On Tuesday shares of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX)…
-
Market Watch List: Cytokinetics, Incorporated (NASDAQ:CYTK), Amicus Therapeutics (NASDAQ:FOLD), Williams-Sonoma Inc. (NYSE:WSM), United Continental Holdings (NYSE:UAL), Amgen Inc. (NASDAQ:AMGN)
Cytokinetics, Inc. (NASDAQ:CYTK) reported a rise of 4% or 53,149 shares in its short interest. The short figure came in at 4.2% of the total floats. The average daily volume of 866,085 shares suggests that the days to cover 1,374,488 short positions, as on December 31,2014, will be 2. On December 15,2014, the short interest…
-
5 Stocks: AOL Inc. (NYSE:AOL), BP p.l.c. (NYSE:BP), Rosetta Resources (NASDAQ:ROSE), Codexis (NASDAQ:CDXS), Cytokinetics, Incorporated (NASDAQ:CYTK)
AOL Inc. (NYSE:AOL) Chief Executive Tim Armstrong dismissed talks of possible mergers with tech and communications giants Yahoo and Verizon on 7 January. On Tuesday shares of AOL Inc. (NYSE:AOL) closed at $47.71. Company’s sales growth for last 5 years was -11.00% and EPS growth for next 5 years is recorded as 11.15%. BP Plc…
-
Mix Sector Stocks: Silicon Motion Technology Corp. (NASDAQ:SIMO), Rite Aid Corporation (NYSE:RAD), Oaktree Capital Group, LLC (NYSE:OAK), Merck (NYSE:MRK), Cytokinetics, Incorporated (NASDAQ:CYTK)
Silicon Motion Technology Corp. (NASDAQ:SIMO) announced the addition of Mr. Gihyun Bae as Senior Vice President for Product Planning and Strategic Business Development. Mr. Bae is a seasoned executive and business leader with over 15 years of operational experience in the NAND flash industry. Silicon Motion Technology Corp. (NASDAQ:SIMO) in last trading activity increased 3.47%…
-
Top News: Cytokinetics, Incorporated (NASDAQ:CYTK), BlackBerry Ltd (NASDAQ:BBRY), MergeWorthRx Corp. (NASDAQ:MWRX), Prothena Corporation plc (NASDAQ:PRTA), AU Optronics Corp. (NYSE:AUO)
Cytokinetics, Incorporated (NASDAQ:CYTK), SVP Fady Ibraham Malik sold 21,630 shares of Cytokinetics stock in a transaction that occurred on Tuesday, December 30th. The stock was sold at an average price of $6.73, for a total transaction of $145,569.90. Cytokinetics, Incorporated (NASDAQ:CYTK) in last trading activity decreased -5.87% to close at $7.22. Company weekly performance is…
-
Stocks Buzz: Tucows Inc. (NASDAQ:TCX), Cytokinetics, Incorporated (NASDAQ:CYTK), ChipMOS TECHNOLOGIES (NASDAQ:IMOS), Rocky Brands (NASDAQ:RCKY), General Electric Company (NYSE:GE)
Tucows Inc. (NYSE:TCX) last issued its quarterly earnings data on Wednesday, November 12th. The company reported $0.24 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.22 by $0.02. The company had revenue of $38.90 million for the quarter, compared to the consensus estimate of $37.60 million. The company’s quarterly revenue was up…
-
Biotech Insider Selling: Cytokinetics (NASDAQ:CYTK), Keryx Biopharmaceuticals (NASDAQ:KERX), Nektar Therapeutics (NASDAQ:NKTR), BioCryst Pharmaceuticals (NASDAQ:BCRX), PTC Therapeutics (NASDAQ:PTCT)
Cytokinetics Incorporated (NASDAQ:CYTK) SVP Fady Ibraham Malik sold 21,630 shares of Cytokinetics stock in a transaction that occurred on Tuesday, December 30th. The stock was sold at an average price of $6.73, for a total value of $145,569.90. Following the completion of the sale, the senior vice president now directly owns 3,361 shares in the…
-
Biotech Decliners: JUNO THERAPEUTICS (NASDAQ:JUNO), Cytokinetics (NASDAQ:CYTK), NeuroDerm (NASDAQ:NDRM), Trevena (NASDAQ:TRVN), Xenon Pharmaceuticals Inc. (NASDAQ:XENE)
Juno Therapeutics (NASDAQ:JUNO) major shareholder Douglas K. Bratton bought 625,000 shares of the stock in a transaction that occurred on Tuesday, December 23rd. The stock was purchased at an average price of $24.00 per share, for a total transaction of $15,000,000.00. JUNO THERAPEUTICS, INC. (NASDAQ:JUNO) in last trading activity decreased -7.60% to close at $48.25.…
-
Investor’s pick: Cytokinetics, Incorporated (NASDAQ:CYTK), Windstream Holdings (NASDAQ:WIN), Silicon Graphics International Corp. (NASDAQ:SGI), Monotype Imaging (NASDAQ:TYPE), Perfect World Co., (NASDAQ:PWRD)
Shares of Cytokinetics (NASDAQ:CYTK) have been given a consensus rating of “Buy” by the seven ratings firms that are covering the company, American Banking & Market News reports. Two equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. Cytokinetics, Incorporated (NASDAQ:CYTK) in last…
-
Investors Are Gambling: Citigroup Inc. (NYSE:C), Cytokinetics, Incorporated (NASDAQ:CYTK), TASER International Inc. (NASDAQ:TASR), Twenty-First Century Fox (NASDAQ:FOXA), GenCorp Inc. (NYSE:GY)
On 26 December Citigroup Inc. (NYSE:C) announced its decision to hand over its Japan-based consumer banking operations to one of the country’s biggest financial groups, Sumitomo Mitsui Financial Grp, Inc.(ADR) (NYSE:SMFG). Citigroup Inc. (NYSE:C) in last trading activity fell -1.33% to close at $54.11. Company weekly performance is -0.57% while its quarterly performance stands at…